Catalyst Wire Dossier Catalyst Wire Dossier

Latanoprost PPDS

latanoprost · Mati Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Latanoprost PPDS, covering 2017-01-18 to 2017-01-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma [Phase 2]

See pricing